Article Link: U.S. Food and Drug Administration Approves Bristol Myers Squibb’s Pomalyst (pomalidomide) for AIDS-Related and HIV-Negative Kaposi Sarco...
Rubraca (rucaparib) Approved in the U.S. as Monotherapy Treatment for Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Article Link: Rubraca (rucaparib) Approved in the U.S. as Monotherapy Treatment for Patients with BRCA1/2-Mutant, Metastatic Castration-Resistant Pros...
FDA Approves Qinlock (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor
Article Link: FDA Approves Qinlock (ripretinib) for the Treatment of Fourth-Line Gastrointestinal Stromal Tumor WALTHAM, Mass.–(BUS...
Breaking News Today Regarding Johns Hopkins Hospital Doctors Using This Product. Up over 55% Since we Initiated Coverage Yesterday. Vuzix (NASDAQ: VUZI) Augmented Reality Provides Zoom for Healthcare.
Breaking News Usage of Vuzix M400 Smart Glasses to Remotely Monitor COVID-19 Patients and Collaborate with Medical Staff Continues to Expand Vuzix gla...
FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers
Article Link: FDA Approves Retevmo (selpercatinib) for Patients with Advanced RET-Driven Lung and Thyroid Cancers INDIANAPOLIS, May 8, 20...
Lynparza (olaparib) Approved by FDA as First-Line Maintenance Treatment with Bevacizumab for HRD-Positive Advanced Ovarian Cancer
Article Link: Lynparza (olaparib) Approved by FDA as First-Line Maintenance Treatment with Bevacizumab for HRD-Positive Advanced Ovarian Cancer ...
Technology for the Future of Healthcare. Tele-Medicine to Explode in Popularity.
VUZI Has Tools for the Future of Healthcare Golden cross formation on the chart, Oversold, Low float, Tele-medicine & wearable tech are both HOT s...
FDA Approves Tabrecta (capmatinib) for Metastatic Non-Small Cell Lung Cancer with METex14
Article Link: FDA Approves Tabrecta (capmatinib) for Metastatic Non-Small Cell Lung Cancer with METex14 EAST HANOVER, N.J., May 6, 2020 /...
Rethinking Technology in the Healthcare System
Good day everyone, Congrats to all who booked up to 90% gains on our first feature report this week! Day to day life is difficult for many of us right...
Farxiga Approved in the US for the Treatment of Heart Failure in Patients with Heart Failure with Reduced Ejection Fraction
Article Link: Farxiga Approved in the US for the Treatment of Heart Failure in Patients with Heart Failure with Reduced Ejection Fraction ...